ABVX

#907
Abivax SA American Depositary Shares
124.03 USD
+2.24%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
124.00
124.89
Rango anual
5.59
148.83
Cambio diario
+2.24%
Variación mensual
+3.36%
Variación en los últimos 6 meses
+26.29%
Cambio anual
+1988.05%
Cierres anteriores
121.31
Abrir
124.71
Bid
Ask
Mínimo
124.00
High
124.89
Volumen
113
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202320242025 TTM

Abivax SA - American Depositary Shares

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

Noticias